IMPORTANCE Postoperative hospital-acquired infections (HAIs) may result from disruption of natural barrier sites. Recent studies have linked vitamin D status and barrier site integrity.
care expenditures attributable to HAIs range from $28 billion to $45 billion, 6 and the average hospital length of stay is prolonged by 5 to 9 days in patients who develop a nosocomial infection. 7 While catheter-related urinary tract infections (CRUTIs) are the most common HAI in the United States, surgical site infections (SSIs), pneumonias, and bloodstream infections are all significant causes of HAIs. 5 Despite a flurry of research on the prevention of nosocomial infections, current understanding of HAIs remains limited. 1, 8 Indeed, existing strategies have only resulted in modest reductions in postoperative infection rates. 2, [9] [10] [11] [12] [13] [14] [15] [16] [17] Temperature regulation, 15, 16 minimization of blood transfusions, 13, 14 and less time under general anesthesia 17 appear to derive their benefit from attenuating surgical stress-induced suppression of the immune system. In essence, robust postoperative immune function is associated with a lower likelihood of HAIs. [18] [19] [20] However, it is important to note that aside from the use of neuraxial anesthesia, all existing strategies to minimize HAIs look to modify factors external to the host. Moreover, to our knowledge, few studies have looked at methods of optimizing natural host responses to infection in the perioperative setting. [18] [19] [20] Recently, the immune-modulating effects of vitamin D have received significant attention. 21 Indeed, a role for vitamin D in the prevention of HAIs has been suggested. 7 However, to date, the influence of vitamin D status on surgical outcomes is largely unknown. 22 A limited number of reports suggests that the prevalence of preoperative vitamin D insufficiency (defined as 25-hydroxyvitamin D [25(OH)D]<30 ng/ mL) may be as high as 70% to 80% in bariatric surgery patients. 23, 24 At the same time, SSI rates in Roux-en-Y gastric bypass surgery patients range from 1% to 10% following laparoscopic procedures to 15% to 25% following open abdominal surgery. 25, 26 Furthermore, obesity is a well-known risk factor for postoperative urinary tract infections and pulmonary complications. 27, 28 As such, our goal was to determine whether preoperative serum 25(OH)D less than 30 ng/mL is associated with a higher risk for postoperative HAIs in patients who undergo Roux-en-Y gastric bypass surgery.
Methods
The need for informed patient consent was waived as the Similarly, a diagnosis of pneumonia was based on previously published guidelines and was defined as the presence of at least 3 of the following criteria during the index admission or during a readmission within 30 days after surgery: (1) leukocytosis; (2) fever; (3) new infiltrate on chest x-ray; (4) positive sputum Gram stain finding; or (5) positive sputum culture finding. 31 As defined in the existing literature, bacteremia required documented evidence of microbial growth from 2 peripheral blood cultures.
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Covariates Each patient's electronic medical record was reviewed to collect information related to the following covariates: (1) age; 
Statistical Analysis
Bivariate tests were used to compare the characteristics of patients who did or did not develop HAIs and, more specifically, SSIs (t test, Mann-Whitney U test, χ 2 test, and Fisher exact test). Propensity score-matched-pairs analyses were used to determine the adjusted association of 25(OH)D level (dichotomized to <30 ng/mL vs ≥30 ng/mL) with the primary out-parsimonious multivariable logistic regression model was developed to estimate propensity scores for the preoperative dichotomized 25(OH)D level, irrespective of outcome. Clinical considerations guided the initial choice of covariates in these models to include: (1) age; (2) sex; (3) race/ethnicity; (4) body mass index; (5) American Society of Anesthesiologists physical status score; (6) medical comorbidities; (7) season; (8) preoperative hemoglobin level; and (9) preoperative vitamin D supplementation status. A structured iterative approach was used to refine the model, with the goal of achieving covariate balance within the matched pairs. Covariate balance was measured using the standardized difference where an absolute standardized difference greater than 10% represented meaningful covariate imbalance. 33, 34 Patients with 25
(OH)D levels less than 30 ng/mL were matched to patients with vitamin D levels 30 ng/mL or greater using a greedy matching algorithm 35 with a caliper width of 0.2 SDs of the log odds of the estimated propensity score. This method involved sampling without replacement.
A multivariable logistic regression model was then constructed to evaluate the association of the dichotomized 25 (OH)D level with HAIs and SSIs using the matched-pairs data, while controlling for other preoperative and intraoperative variables that might be associated with nosocomial infections based on clinical considerations. These variables included (1) type of surgery; (2) duration of general anesthesia; (3) intraoperative fluid balance; (4) intraoperative temperature nadir; (5) intraoperative fraction of inspired oxygen concentration; and (6) preoperative albumin level.
Sensitivity analyses for the robustness of the propensity score matching was performed using multivariable logistic regression on the entire patient sample (N = 770) to determine the association of preoperative 25(OH)D level with HAIs and SSIs while adjusting for (1) age; (2) sex; (3) race/ethnicity; (4) body mass index; (5) American Society of Anesthesiologists physical status score; (6) medical comorbidities; (7) Locally weighted scatter plot smoothing (LOWESS) was used to graphically represent the relationship between preoperative 25(OH)D level and the risk for HAIs and SSIs. Locally weighted scatter plot smoothing is a type of nonparametric regression, which summarizes a relationship between 2 variables in a fashion that initially relies on limited assumptions about the form or strength of the relationship. 36 The rationale and methods underlying the use of LOWESS for depicting the local relationship between measurements of interest across parts of their ranges have previously been described. 37 All analyses were performed using Stata version 10 (StataCorp LP). All P values were 2-tailed, with statistical significance defined by P < .05.
Results
Of an identified 802 patients, 770 met the inclusion criteria. The 32 excluded cases comprised 3 patients with missing baseline 25(OH)D levels and 29 patients with levels that were obtained more than 30 days before surgery. The overall HAI rate in the study cohort was 5.3% (n = 41) and the SSI rate was 2.6% (n = 20). The overall prevalence of preoperative 25(OH)D less than 30 ng/mL in the study cohort was 58%.
A comparison of baseline characteristics between HAI and non-HAI patients demonstrated no substantial differences between groups except for a difference in preoperative 25(OH)D levels and a slightly higher rate of open Rouxen-Y gastric bypass surgical procedures in the HAI group compared with the non-HAI group (Table) . Similar comparison of baseline characteristics between SSI and non-SSI patients demonstrated no substantial differences between groups except for a difference in preoperative 25(OH)D levels, a slightly higher rate of chronic obstructive pulmonary disease in the SSI group, and a statistically (but not clinically) significant difference in preoperative albumin levels (Table) .
Propensity score matching, based on the selection of clinically relevant variables outlined in the Methods section, resulted in a reduction of the sample size from 770 to 544 patients. Compared with patients with baseline 25(OH)D levels less than 30 ng/mL, patients with 25(OH)D levels 30 ng/mL or greater had an adjusted odds ratio (OR) of 3.05 (95% CI, 1.34-6.94) for HAIs and of 4.14 (95% CI, 1.16-14.83) for SSIs. In a sensitivity analysis, we compared patients with baseline 25(OH)D levels less than 30 ng/mL to patients with 25(OH)D levels 30 ng/mL or greater in the entire study cohort (n = 770) and found that those with lower 25(OH)D had an adjusted OR of 3.00 (95% CI, 1.31-6.89) for HAIs and an adjusted OR of 3.93 (95% CI, 1.08-14.19) for SSIs.
Multivariable logistic regression analyses to examine the relationship between preoperative 25(OH)D level and HAI/SSI using the propensity score-matched sample together with other potential perioperative confounders, as described in the Methods section, resulted in a further reduction in sample size to 502 patients. Comparing patients with baseline 25(OH)D levels less than 30 ng/mL to patients with 25(OH)D levels 30 ng/mL or greater in this fully adjusted model resulted in an OR of 2.91 (95% CI, 1.25-6.76) for HAIs and an OR of 4.32 (95% CI, 1.16-16.17) for SSIs. Repeated sensitivity analysis, as described in the Methods section, and comparing patients with baseline 25(OH)D levels less than 30 ng/mL to patients with 25(OH)D levels 30 ng/mL or greater in the final study cohort (n = 502) resulted in an adjusted OR of 2.92 (95% CI, 1.23-6.96) for HAIs and an adjusted OR of 4.37 (95% CI, 1.12-16.51) for SSIs.
Locally weighted scatter plot smoothing plots ( Figure 1 and To control for potential confounding in this observational study, we used propensity score matching based on a set of conservative a priori parameters. This resulted in the exclusion of 226 patients from the original patient cohort. Sensitivity analysis confirmed that the observed association between 25(OH)D levels and the risk for HAIs (and SSIs) was consistent whether multivariable logistic regression analysis was performed using the propensity score-matched cohort or the entire study cohort. Adjustment of the propensity scorematched cohort for additional perioperative factors resulted in a further modest reduction in sample size. However, repeated sensitivity analysis confirmed the validity of the fully adjusted model and its ability to represent the associations between vitamin D status and the risk for nosocomial infections in the overall study cohort.
The decision to dichotomize the 25(OH)D level at less than 30 ng/mL and 30 ng/mL or greater for the matched propensity score analysis was a priori and based on several factors. 42 In humans, LL-37 has been shown to have potent activity against bacteria, viruses, fungi, and mycobacteria, 45 and it is highly expressed at barrier sites. As such, LL-37 may provide important first-line defense mechanisms for the innate immune system. 46 Prospective studies by members of our research group and others have shown maximal LL-37 expression to occur at 25(OH)D levels between 30 and 35 ng/mL, 47, 48 thereby strengthening the biological basis for the association between higher 25(OH)D levels and optimal immune function. While our results support emerging insights on the pathophysiology of postoperative infections, it is important to discuss a number of possible study limitations. First, almost all patients underwent a laparoscopic procedure and thus had a significantly lower overall risk for SSIs; however, this was balanced with a relatively high prevalence of vitamin D insufficiency in the study cohort. Indeed, the overall SSI rate in our patient sample (2.6%) is in line with published reports. On the other hand, our rate of HAIs (5.3%) is slightly lower than published reports (7%-8%) and likely reflects some of the advan- 
